Revenue: The sum of all revenue fields included for a company's operating activities.
PTC Therapeutics, Inc. (PTCT) had Revenue of $360.52M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$360.52M |
$83.50M |
|
$19.92M |
|
$340.60M |
|
$211.54M |
|
$148.98M |
|
$-51.43M |
|
$97.55M |
|
$97.55M |
|
$83.50M |
|
$83.50M |
|
$83.50M |
|
$83.50M |
|
$148.98M |
|
$160.15M |
|
83.01M |
|
92.02M |
|
$1.01 |
|
$0.92 |
|
| Balance Sheet Financials | |
$2.62B |
|
$51.49M |
|
$633.12M |
|
$3.25B |
|
$771.07M |
|
$2.54B |
|
$2.64B |
|
$3.42B |
|
$-165.36M |
|
$-650.63M |
|
$-165.36M |
|
83.33M |
|
| Cash Flow Statement Financials | |
$70.07M |
|
$-216.29M |
|
$218.28M |
|
$998.33M |
|
$1.07B |
|
$68.00M |
|
$46.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.39 |
|
-- |
|
-- |
|
1.07 |
|
-17.65 |
|
94.47% |
|
41.32% |
|
41.32% |
|
-- |
|
27.06% |
|
23.16% |
|
$66.68M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.22 |
|
1.51 |
|
59.67 |
|
-50.49% |
|
-12.83% |
|
2.57% |
|
3.51% |
|
$-1.98 |
|
$0.72 |
|
$0.76 |
|